Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 44

1.

Menstrual Suppression for Military Women: Barriers to Care in the United States.

Criscione L, Hunkler K, Eubanks A, Saunders R.

Obstet Gynecol. 2019 Nov;134(5):1118-1119. doi: 10.1097/AOG.0000000000003542. No abstract available.

PMID:
31651821
2.

Comment on "a peptidomimetic targeting white fat causes weight loss and improved insulin resistance in obese monkeys".

Criscione L.

Sci Transl Med. 2012 Apr 25;4(131):131le2; author reply 131lr2. doi: 10.1126/scitranslmed.3003760.

3.

Diurnal variation of serum and urine biomarkers in patients with radiographic knee osteoarthritis.

Kong SY, Stabler TV, Criscione LG, Elliott AL, Jordan JM, Kraus VB.

Arthritis Rheum. 2006 Aug;54(8):2496-504.

4.

Variation of serum hyaluronan with activity in individuals with knee osteoarthritis.

Criscione LG, Elliott AL, Stabler T, Jordan JM, Pieper CF, Kraus VB.

Osteoarthritis Cartilage. 2005 Sep;13(9):837-40.

5.

B lymphocytes and systemic lupus erythematosus.

Criscione LG, Pisetsky DS.

Curr Rheumatol Rep. 2003 Aug;5(4):264-9. Review.

PMID:
14531953
6.

Authorities should note sponsorship--results link.

Criscione L.

Nature. 2003 Jul 24;424(6947):369. No abstract available.

PMID:
12879038
7.

Informed consent in a clinical trial of a novel treatment for rheumatoid arthritis.

Criscione LG, Sugarman J, Sanders L, Pisetsky DS, St Clair EW.

Arthritis Rheum. 2003 Jun 15;49(3):361-7.

8.

Tumor necrosis factor-alpha antagonists for the treatment of rheumatic diseases.

Criscione LG, St Clair EW.

Curr Opin Rheumatol. 2002 May;14(3):204-11. Review.

PMID:
11981314
9.

Design, synthesis and SAR of a series of 2-substituted 4-amino-quinazoline neuropeptide Y Y5 receptor antagonists.

Rueeger H, Rigollier P, Yamaguchi Y, Schmidlin T, Schilling W, Criscione L, Whitebread S, Chiesi M, Walker MW, Dhanoa D, Islam I, Zhang J, Gluchowski C.

Bioorg Med Chem Lett. 2000 Jun 5;10(11):1175-9.

PMID:
10866375
10.

Food intake in free-feeding and energy-deprived lean rats is mediated by the neuropeptide Y5 receptor.

Criscione L, Rigollier P, Batzl-Hartmann C, Rüeger H, Stricker-Krongrad A, Wyss P, Brunner L, Whitebread S, Yamaguchi Y, Gerald C, Heurich RO, Walker MW, Chiesi M, Schilling W, Hofbauer KG, Levens N.

J Clin Invest. 1998 Dec 15;102(12):2136-45.

11.

The pharmacology of neuropeptide Y (NPY) receptor-mediated feeding in rats characterizes better Y5 than Y1, but not Y2 or Y4 subtypes.

Wyss P, Stricker-Krongrad A, Brunner L, Miller J, Crossthwaite A, Whitebread S, Criscione L.

Regul Pept. 1998 Sep 25;75-76:363-71.

PMID:
9802430
12.

Cytokines in murine lyme carditis: Th1 cytokine expression follows expression of proinflammatory cytokines in a susceptible mouse strain.

Kelleher Doyle M, Telford SR 3rd, Criscione L, Lin SR, Spielman A, Gravallese EM.

J Infect Dis. 1998 Jan;177(1):242-6.

PMID:
9419199
13.

Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides.

Schaffhauser AO, Stricker-Krongrad A, Brunner L, Cumin F, Gerald C, Whitebread S, Criscione L, Hofbauer KG.

Diabetes. 1997 Nov;46(11):1792-8.

PMID:
9356028
14.

A receptor subtype involved in neuropeptide-Y-induced food intake.

Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL, Schaffhauser AO, Whitebread S, Hofbauer KG, Taber RI, Branchek TA, Weinshank RL.

Nature. 1996 Jul 11;382(6587):168-71.

PMID:
8700207
15.

Mechanism of interaction between neuropeptide Y and angiotensin II in the rabbit femoral artery.

Cressier F, Criscione L, Hofbauer KG.

Eur J Pharmacol. 1995 Jan 5;272(1):57-65.

PMID:
7713150
16.
17.

Antihypertensive therapy augments endothelium-dependent relaxations in coronary arteries of spontaneously hypertensive rats.

Tschudi MR, Criscione L, Novosel D, Pfeiffer K, Lüscher TF.

Circulation. 1994 May;89(5):2212-8.

PMID:
8181147
18.

Pharmacological profile of valsartan: a potent, orally active, nonpeptide antagonist of the angiotensin II AT1-receptor subtype.

Criscione L, de Gasparo M, Bühlmayer P, Whitebread S, Ramjoué HP, Wood J.

Br J Pharmacol. 1993 Oct;110(2):761-71.

19.

Endothelium-dependent relaxant effect of neurokinins on rabbit aorta is mediated by the NK1 receptor.

Rubino A, Thomann H, Henlin JM, Schilling W, Criscione L.

Eur J Pharmacol. 1992 Mar 3;212(2-3):237-40.

PMID:
1318213
20.
21.

Effect of aging and hypertension on endothelial function of rat coronary arteries.

Tschudi MR, Criscione L, Lüscher TF.

J Hypertens Suppl. 1991 Dec;9(6):S164-5. No abstract available.

PMID:
1818925
22.

Nonpeptidic angiotensin II antagonists: synthesis and in vitro activity of a series of novel naphthalene and tetrahydronaphthalene derivatives.

Bühlmayer P, Criscione L, Fuhrer W, Furet P, de Gasparo M, Stutz S, Whitebread S.

J Med Chem. 1991 Oct;34(10):3105-14.

PMID:
1920360
24.

Effect of covalent dimer conjugates of angiotensin II on receptor affinity and activity in vitro.

de Gasparo M, Whitebread S, Kamber B, Criscione L, Thomann H, Riniker B, Andreatta R.

J Recept Res. 1991;11(1-4):247-57.

PMID:
1886081
25.

Influence of NG-monomethyl-L-arginine on endothelium-dependent relaxations in the perfused mesenteric vascular bed of the rat.

Ebeigbe AB, Cressier F, Konneh MK, Luu TD, Criscione L.

Biochem Biophys Res Commun. 1990 Jun 29;169(3):873-9.

PMID:
2363729
26.

Sarmesin is a partial agonist of angiotensin-II receptors in rabbit, but not in rat, aortic rings.

Criscione L, Thomann H, Whitebread S, de Gasparo M, Kamber B.

Biochem Biophys Res Commun. 1990 Jun 15;169(2):636-42.

PMID:
2357223
27.
28.

Sensitivity to endothelin-1 in mesenteric beds and aortic rings of 4-week-old spontaneously hypertensive rats.

Criscione L, Thomann H, Luu TD.

Acta Physiol Hung. 1990;75 Suppl:67-8. No abstract available.

PMID:
2196760
29.

Binding characteristics and vascular effects of various angiotensin II antagonists.

Criscione L, Thomann H, Whitebread S, de Gasparo M, Bühlmayer P, Herold P, Ostermayer F, Kamber B.

J Cardiovasc Pharmacol. 1990;16 Suppl 4:S56-9.

PMID:
1705629
30.

Blood pressure, the renin-angiotensin system and neurogenic vasoconstriction in pithed rats.

Henrion D, Eglème C, Criscione L, Wood JM.

J Pharm Pharmacol. 1989 Nov;41(11):766-9.

PMID:
2576045
31.

Blockade of endothelin-induced contractions by dichlorobenzamil: mechanism of action.

Criscione L, Thomann H, Rodriguez C, Eglème C, Chiesi M.

Biochem Biophys Res Commun. 1989 Aug 30;163(1):247-54.

PMID:
2505766
32.

CGP 38 560: orally active, low-molecular-weight renin inhibitor with high potency and specificity.

Wood JM, Criscione L, de Gasparo M, Bühlmayer P, Rüeger H, Stanton JL, Jupp RA, Kay J.

J Cardiovasc Pharmacol. 1989 Aug;14(2):221-6.

PMID:
2476594
33.

Alcohol suppresses endothelium-dependent relaxation in rat mesenteric vascular beds.

Criscione L, Powell JR, Burdet R, Engesser S, Schlager F, Schoepfer A.

Hypertension. 1989 Jun;13(6 Pt 2):964-7.

PMID:
2786850
34.

Synthesis and biological activity of some transition-state inhibitors of human renin.

Bühlmayer P, Caselli A, Fuhrer W, Göschke R, Rasetti V, Rüeger H, Stanton JL, Criscione L, Wood JM.

J Med Chem. 1988 Sep;31(9):1839-46.

PMID:
3137345
35.

Systemic and regional hemodynamic effects of atriopeptin II in anesthetized rats.

Criscione L, Burdet R, Hänni H, Kamber B, Truog A, Hofbauer KG.

J Cardiovasc Pharmacol. 1987 Feb;9(2):135-41.

PMID:
2435989
36.

Absence of reflex sympathetic activation by the selective renal vasodilator CGP 22979A in the conscious rat.

Criscione L, Cave A, Burdet R, Hofbauer KG.

Clin Exp Hypertens A. 1987;9 Suppl 1:319-26.

PMID:
3677458
37.

Acute and chronic haemodynamic and natriuretic effects of atriopeptin II in conscious rats.

Hofbauer KG, Criscione L, Sonnenburg C, Muir A, Mah SC.

J Hypertens Suppl. 1986 Jun;4(2):S41-7.

PMID:
2941543
38.

Hydralazine and its metabolites: in vitro and in vivo activity in the rat.

Criscione L, Eichenberger K, Hedwall PR, Schmid K.

J Cardiovasc Pharmacol. 1986 Mar-Apr;8(2):420-7.

PMID:
2422484
39.

Is the natriuretic effect of atrial natriuretic factor in conscious rats mediated by renal vasodilatation?

Sonnenburg C, Muir AC, Criscione L, Kraetz J, Hofbauer KG.

J Hypertens Suppl. 1985 Dec;3(3):S303-5.

PMID:
2856723
40.

CGP 22979A, a renal vasodilator with natriuretic properties.

Hofbauer KG, Sonnenburg C, Stalder R, Criscione L, Kraetz J, Fuhrer W, Habicht E.

J Pharmacol Exp Ther. 1985 Mar;232(3):838-44.

PMID:
3973831
41.

In vitro comparative studies of the calcium-entry activators YC-170, CGP 28392, and BAY K 8644.

Rogg H, Criscione L, Truog A, Meier M.

J Cardiovasc Pharmacol. 1985;7 Suppl 6:S31-7.

PMID:
2414592
42.

Endothelial cell loss enhances the pressor response in resistance vessels.

Criscione L, Müller K, Forney Prescott M.

J Hypertens Suppl. 1984 Dec;2(3):S441-4.

PMID:
6599695
43.

Cholinergic mechanisms in the nucleus tractus solitarii and cardiovascular regulation in the rat.

Criscione L, Reis DJ, Talman WT.

Eur J Pharmacol. 1983 Mar 18;88(1):47-55.

PMID:
6852105
44.

An iridium-iridium oxide electrode for in vivo monitoring of blood pH changes.

Papeschi G, Bordi S, Carlà M, Criscione L, Ledda F.

J Med Eng Technol. 1981 Mar;5(2):86-8.

PMID:
7277452

Supplemental Content

Loading ...
Support Center